Zobrazeno 1 - 10
of 230
pro vyhledávání: '"Gentiloni, P."'
Flow Matching (FM) (also referred to as stochastic interpolants or rectified flows) stands out as a class of generative models that aims to bridge in finite time the target distribution $\nu^\star$ with an auxiliary distribution $\mu$, leveraging a f
Externí odkaz:
http://arxiv.org/abs/2409.08311
Autor:
Claudia Alteri, Antonio Teri, Maria Francesca Liporace, Antonio Muscatello, Leonardo Terranova, Margherita Carnevale Schianca, Federica Salari, Beatrice Silvia Orena, Flaminia Gentiloni Silverj, Mara Bernazzani, Simona Biscarini, Giulia Renisi, Lisa Cariani, Caterina Matinato, Ciro Canetta, Alessandra Bandera, Annapaola Callegaro
Publikováno v:
Annals of Clinical Microbiology and Antimicrobials, Vol 23, Iss 1, Pp 1-6 (2024)
Abstract Background During prolonged FDC therapy, the emergence of FDC non-susceptibility in CRAB has been reported. Here, we report a transmission cluster of FDC-non-susceptible CRAB in four patients, all naïve to FDC treatment, characterized by a
Externí odkaz:
https://doaj.org/article/5e9dc14a5f7e499788241413d2e4b218
Diffusion models are a new class of generative models that revolve around the estimation of the score function associated with a stochastic differential equation. Subsequent to its acquisition, the approximated score function is then harnessed to sim
Externí odkaz:
http://arxiv.org/abs/2308.12240
Autor:
Roberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, Fabiola Atzeni, Angelo Semeraro, Salvatore D’Angelo, Carlo Selmi, Augusta Ortolan, Antonio Marchesoni, Maria Manara, Michele Maria Luchetti Gentiloni, Leonardo Santo, Carlo Salvarani, Alberto Cauli, Maurizio Rossini, Giorgio Amato, Giacomo Cozzi, Laura Scagnellato, Mario Ferraioli, Antonio Carriero, Elena Fracassi, Francesco Giorgio, Andrea Doria, Rosario Foti, Antonio Carletto, on behalf Spondyloarthritis and Psoriatic Arthritis SIR Study Group “Antonio Spadaro”
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-16 (2024)
Abstract Objectives to evaluate over a 48-month follow-up period the: 1) long-term effectiveness and safety; 2) drug retention rate (DRR); 3) impact of comorbidities and bDMARDs line on MDA and DAPSA remission/low disease activity (LDA) of secukinuma
Externí odkaz:
https://doaj.org/article/3ca00c18f62e4f93a4c5e5ec400982f1
Autor:
Beatrice Silvia Orena, Maria Francesca Liporace, Antonio Teri, Daniela Girelli, Federica Salari, Michela Mutti, Gabriele Giordano, Claudia Alteri, Flaminia Gentiloni Silverj, Caterina Matinato, Annapaola Callegaro, Lisa Cariani
Publikováno v:
Antibiotics, Vol 13, Iss 11, p 1053 (2024)
Background/Objectives: Carbapenem-resistant Enterobacteriaceae (CRE) are types of bacteria that need urgent attention globally. Active surveillance programs at hospitals are essential for the early identification of CRE carriers and the timely adopti
Externí odkaz:
https://doaj.org/article/dbe939450b5042b5a5e6d5114bee5a6f
Autor:
Roberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, Salvatore D’Angelo, Antonio Marchesoni, Carlo Selmi, Ennio Lubrano, Leonardo Santo, Michele Maria Luchetti Gentiloni, Fabiola Atzeni, Alberto Cauli, Maria Manara, Maurizio Rossini, Roberta Foti, Giacomo Cozzi, Laura Scagnellato, Mario Ferraioli, Antonio Carriero, Nicoletta Luciano, Francesca Ruzzon, Mauro Fatica, Elena Fracassi, Andrea Doria, Rosario Foti, Antonio Carletto
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
ObjectivesThis study aims to evaluate in a real-life Italian multicenter cohort of axial spondyloarthritis (axSpA) (1) the 4-year effectiveness and safety of secukinumab, (2) the drug retention rate (DRR), and (3) the impact of the line of bDMARDs tr
Externí odkaz:
https://doaj.org/article/86d5f27379ea4c54bd044f296c966792
Autor:
Michele Maria Luchetti Gentiloni, Valentino Paci, Antonio Carletto, Alen Zabotti, Roberta Ramonda, Maria Sole Chimenti, Lorenzo Dagna, Nicoletta Luciano, Anna Piccinelli, Ivan Giovannini, Giovanni Striani, Nicola Boffini, Gilda Sandri, Niccolò Possemato, Ilenia Pantano, Devis Benfaremo, Carlo Salvarani, Francesco Ciccia, Carlo Selmi, Gianluca Moroncini
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-11 (2023)
Abstract Background Upadacitinib (UPA) is a selective JAK inhibitor recently approved for the treatment of psoriatic arthritis (PsA). In this post-approval study, we aimed to evaluate the effectiveness and safety of UPA over 24 weeks and identify cli
Externí odkaz:
https://doaj.org/article/108d482682b9424eb9e04468ca9fdd9d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.